USH2A Clinical Trial Webinar, presented by ProQR

The content in this page is take from the Usher Syndrome Coalition website and it is of their property. We…

Wednesday February 23rd, 2022

QR-421a: Showing Benefits on One out of Four Usher Syndrome patients

Original article on AP News QR-421a showed early and encouraging evidence of activity, with 25% of patients showing a benefit…

Thursday April 2nd, 2020

QR-421a and the clinical trials on Usher Syndrome Type 2A

ProQR is developing a novel investigational drug called QR-421a to treat RP in patients that have USH2 due to a…

Tuesday October 1st, 2019